Potassium and Kalbitor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Kalbitor (ecallantide). Common drug interactions include hereditary angioedema among females and neoplasm malignant among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Kalbitor. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,147 Potassium users. Check the latest studies of Potassium.

What is Kalbitor?

Kalbitor has active ingredients of ecallantide. eHealthMe is studying from 2,079 Kalbitor users. Check the latest studies of Kalbitor.



On Jul, 17, 2026

36 people who take Potassium and Kalbitor together, and have interactions are studied.

Potassium and Kalbitor drug interactions.

What are the common drug interactions of Potassium and Kalbitor, by gender? *:

female:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Abdominal distension
  3. Dyspnoea (difficult or laboured respiration)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Drug ineffective
  6. Fall
  7. Foot fracture
  8. Upper limb fracture
  9. Arthralgia (joint pain)
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

male:

  1. Neoplasm malignant (cancer tumour)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Nasopharyngitis (inflammation of the nasopharynx)
  4. Pneumonia
  5. Therapeutic response decreased (less preventive response)
  6. Abdominal distension
  7. Cardiomegaly (increased size of heart than normal)
  8. Chest discomfort
  9. Chest pain
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Potassium and Kalbitor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Depressed mood
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Blood cholesterol decreased
  6. Haemoglobin decreased
  7. Hereditary angioedema (recurrent episodes of severe swelling)

40-49:

  1. Neoplasm malignant (cancer tumour)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Cardiomegaly (increased size of heart than normal)
  4. Chest discomfort
  5. Chest pain
  6. Dyspnoea (difficult or laboured respiration)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Therapeutic response decreased (less preventive response)

50-59:

  1. Arthralgia (joint pain)
  2. Hereditary angioedema (recurrent episodes of severe swelling)
  3. Pneumonia
  4. White blood cell count increased
  5. Colon cancer
  6. Memory impairment
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Abdominal distension
  9. Hyperhidrosis (abnormally increased sweating)
  10. Lethargy (tiredness)

60+:

  1. Drug ineffective
  2. Sinusitis (inflammation of sinus)
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Therapeutic response decreased (less preventive response)
  5. Upper respiratory tract infection
  6. Abdominal distension
  7. Dyspnoea (difficult or laboured respiration)
  8. Hepatic cyst
  9. Hereditary angioedema (recurrent episodes of severe swelling)
  10. Pain

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 28 people, 77.78%
  2. Immune System Disorder: 9 people, 25.00%
  3. High Blood Pressure: 3 people, 8.33%
  4. Post-Traumatic Stress Disorder: 2 people, 5.56%
  5. Muscle Spasms (muscle contraction): 2 people, 5.56%
  6. Gout (uric acid crystals building up in the body): 2 people, 5.56%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.56%
  8. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Kalbitor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium and Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kalbitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium and ecallantide (the active ingredients of Potassium and Kalbitor, respectively), and Potassium and Kalbitor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: